Document is current
Any future updates will be listed below
-
Authors
Collins, Meghan A. http://orcid.org/0000-0002-2534-1798
Ji, Jie Lisa http://orcid.org/0000-0002-6280-9070
Chung, Yoonho http://orcid.org/0000-0002-8005-3940
Lympus, Cole A. http://orcid.org/0000-0002-5476-5821
Afriyie-Agyemang, Yvette
Addington, Jean M. http://orcid.org/0000-0002-8298-0756
Goodyear, Bradley G.
Bearden, Carrie E. http://orcid.org/0000-0002-8516-923X
Cadenhead, Kristin S.
Mirzakhanian, Heline
Tsuang, Ming T. http://orcid.org/0000-0002-0076-5340
Cornblatt, Barbara A.
Carrión, Ricardo E.
Keshavan, Matcheri http://orcid.org/0000-0002-5945-888X
Stone, Wiliam S. http://orcid.org/0000-0003-2932-7288
Mathalon, Daniel H. http://orcid.org/0000-0001-6090-4974
Perkins, Diana O.
Walker, Elaine F.
Woods, Scott W.
Powers, Albert R. http://orcid.org/0000-0003-3057-5043
Anticevic, Alan
Cannon, Tyrone D. http://orcid.org/0000-0002-5632-3154
-
Funding
Funding for this research was provided by:
National Science Foundation (DGE-1752134)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (T32MH125786, U01MH081984, U01MH081902, U01MH081944, UO1MH081857, U01MH081928, U01MH076989, U01MH082004, U01MH081988, U01MH082022, 1U01MH121766, 5R01MH112189, 5R01MH108590, U01MH081902)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 16 December 2021
Revised: 27 October 2022
Accepted: 2 November 2022
First Online: 25 November 2022
Competing interests
: MAC, YC, CAL, YAA, JMA, CEB, TDC, KSC, BAC, DPP, MTT, and EFW have no biomedical financial interests or conflicts of interest to disclose. DHM is a consultant for Boehringer-Ingelheim, Cadent Therapeutics, Recognify, and Syndisi. SWW reports that during the last 36 months he has received sponsor-initiated research funding support from Teva, Boehringer-Ingelheim, Amarex, and SyneuRx. He has consulted to Boehringer-Ingelheim, New England Research Institute, and Takeda. He has been granted US patent no. 8492418 B2 for a method of treating prodromal schizophrenia with glycine agonists and has received royalties from Oxford University Press. JLJ previously consulted for Neumora (formerly BlackThorn Therapeutics) and is a co-inventor for the following pending patent: Anticevic A, Murray JD, Ji JL: Systems and Methods for Neuro-Behavioural Relationships in Dimensional Geometric Embedding (N-BRIDGE), PCT International Application No.PCT/US2119/022110, filed March 13, 2019. JLJ is an employee of Manifest Technologies. AA consults for and holds equity with Neumora (formerly BlackThorn Therapeutics), Manifest Technologies, and is a co-inventor on the following patents: Anticevic A, Murray JD, Ji JL: Systems and Methods for Neuro-Behavioural Relationships in Dimensional Geometric Embedding (N-BRIDGE), PCT International Application No. PCT/US2119/022110, filed March 13, 2019 and Murray JD, Anticevic A, Martin WJ: Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject, U.S. Application No. 16/149,903 filed on October 2, 2018, U.S. Application for PCT International Application No. 18/054,009 filed on October 2, 2018.
